Liminatus Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cerritos, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Liminatus Pharma, Inc. has filed 91 SEC EDGAR filings since 02 May 2023

SEC filing history

Showing 1-25 of 91 matching filings.

Per page
25
Current page
1
424B3 File 333-293364

424B3

Filing date
03 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95001

SCHEDULE 13G filing

Filing date
20 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-293364

424B4

Filing date
18 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-293364

EFFECT filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 377-08901

UPLOAD filing

Filing date
06 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-08901

DRS filing

Filing date
31 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
15 Aug 2025
Reporting date
30 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-42626

NT 10-Q

Filing date
15 Aug 2025
Reporting date
30 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .